BE879263A - 2-METHYL-DIHYDROPYRIDINE COMPOUND, METHODS FOR OBTAINING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - Google Patents

2-METHYL-DIHYDROPYRIDINE COMPOUND, METHODS FOR OBTAINING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

Info

Publication number
BE879263A
BE879263A BE0/197526A BE197526A BE879263A BE 879263 A BE879263 A BE 879263A BE 0/197526 A BE0/197526 A BE 0/197526A BE 197526 A BE197526 A BE 197526A BE 879263 A BE879263 A BE 879263A
Authority
BE
Belgium
Prior art keywords
same
methyl
methods
pharmaceutical composition
composition containing
Prior art date
Application number
BE0/197526A
Other languages
French (fr)
Inventor
Y Sato
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BE879263A publication Critical patent/BE879263A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
BE0/197526A 1978-10-10 1979-10-08 2-METHYL-DIHYDROPYRIDINE COMPOUND, METHODS FOR OBTAINING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME BE879263A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7839978 1978-10-10

Publications (1)

Publication Number Publication Date
BE879263A true BE879263A (en) 1980-04-08

Family

ID=10500226

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/197526A BE879263A (en) 1978-10-10 1979-10-08 2-METHYL-DIHYDROPYRIDINE COMPOUND, METHODS FOR OBTAINING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

Country Status (10)

Country Link
JP (2) JPS5562065A (en)
BE (1) BE879263A (en)
CA (1) CA1117117A (en)
CH (1) CH642353A5 (en)
DE (1) DE2940833A1 (en)
FR (1) FR2438654A1 (en)
GB (1) GB2036722B (en)
IT (1) IT1125469B (en)
NL (1) NL7907482A (en)
SE (2) SE446265B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7910521L (en) * 1979-12-20 1981-06-21 Haessle Ab NEW 2-METHYL-6-SUBSTITUTED-4- (2,3-DISUBSTITUTED PHENYL) -1,4-DIHYDROPYRIDINE-3,5-DIESTERS WITH HYPOTHESIVE PROPERTIES, AND PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION
JPS57175164A (en) * 1981-04-18 1982-10-28 Banyu Pharmaceut Co Ltd 1,4-dihydropyridine derivative and its preparation
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
CH655110A5 (en) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd CARBOSTYRILE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM.
DE3312216A1 (en) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING SYMMETRIC 1,4-DIHYDROPYRIDINE CARBONIC ACID ESTERS
JPS6038322A (en) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd Easily soluble solid preparation containing dihydropyridine-a substance
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
GB8602518D0 (en) * 1986-02-01 1986-03-05 Wyeth John & Brother Ltd 1 4-dihydropyridines
JPS63115890A (en) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd 2-substituted 1,4-dihydropyridine derivative
US5114946A (en) * 1987-06-12 1992-05-19 American Cyanamid Company Transdermal delivery of pharmaceuticals
DE3877630T2 (en) * 1987-06-12 1993-06-03 American Cyanamid Co TRANSCUTANEOUS ADMINISTRATION OF PHARMACEUTICALS.
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
EP0322747B1 (en) * 1987-12-29 1994-03-02 Fujisawa Pharmaceutical Co., Ltd. A brain neuron protecting agent containing a dihydropyridine compound
DE3889532T2 (en) * 1987-12-29 1994-08-25 Fujisawa Pharmaceutical Co Dihydropyridine compound to improve vein expansion and inhibition of cardiac hypertrophy.
JP2007230869A (en) * 2004-04-05 2007-09-13 Takeda Chem Ind Ltd Aldosterone receptor antagonist
CN101987833B (en) * 2009-08-04 2014-07-30 北京利乐生制药科技有限公司 Nilvadipine crystal form and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
DE2658183A1 (en) * 1976-12-22 1978-07-06 Bayer Ag 2-POSITION SUBSTITUTED 1,4-DIHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
SE8400689D0 (en) 1984-02-09
FR2438654A1 (en) 1980-05-09
GB2036722A (en) 1980-07-02
DE2940833C2 (en) 1989-01-26
SE446096B (en) 1986-08-11
SE446265B (en) 1986-08-25
IT7926362A0 (en) 1979-10-09
JPS6143343B2 (en) 1986-09-26
SE8400689L (en) 1984-02-09
SE7908367L (en) 1980-04-11
JPS61118366A (en) 1986-06-05
FR2438654B1 (en) 1983-01-14
IT1125469B (en) 1986-05-14
JPS6125711B2 (en) 1986-06-17
CA1117117A (en) 1982-01-26
DE2940833A1 (en) 1980-04-30
GB2036722B (en) 1982-12-01
CH642353A5 (en) 1984-04-13
NL7907482A (en) 1980-04-14
JPS5562065A (en) 1980-05-10

Similar Documents

Publication Publication Date Title
PT64770B (en) PROCESS FOR THE PREPARATION OF AN INSECTICIDE COMPOSITION CONTAINING ETHERS BENZOILIDEIDE-DIFENILICOS
BE873526A (en) CONSTRUCTION MATERIALS ADDITIONAL PRODUCT
NL930110I1 (en) Carbazolyl- (4) -oxypropanolamine derivatives, method of preparation thereof, and medicaments containing these compounds
PH16326A (en) New chemical compounds,pharmaceutical compositions containing the same and method of use
FR2530143B1 (en) MEDICINAL COMPOSITION CONTAINING PIRPROFEN
IT8019049A0 (en) COMPOUNDS 2 PENEM, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS.
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
PT64771B (en) PROCESS FOR THE PREPARATION OF AN INSECTICIDE COMPOSITION CONTAINING ETHERS BENZOILUREID-NITRO-DIFENILICOS
FR2527597B1 (en) ALCOHOL B DERIVATIVES, G-DIHYDROPOLYPRENYLIC AND PHARMACEUTICAL COMPOSITION CONTAINING A POLYPRENYLIC COMPOUND
FI822670A0 (en) ERGOPEPTINDERIVAT, FOERFARANDEN FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION OCH DERAS ANVAENDNING VID TERAPEUTISK BEHANDLING
BE879472A (en) PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DIHYDRO-3-OXO-2-QUINOXALINES
RO85294A (en) SINERGIC INSECTICIDE COMPOSITION
FR2450814B1 (en) 24,24-DIFLUORO-25-HYDROXYCHOLECALCIFEROL AND PHARMACEUTICAL COMPOSITION CONTAINING THIS PRODUCT
IT7949064A0 (en) IMPROVEMENT IN PHARMACEUTICAL COMPOSITIONS CONTAINING PROSTAGLANDIN
FI821051A0 (en) PULVERFORMED COMPOSITION INNEHAOLLANDE PESTICIDER OCH LAEMPLIG FOER BEHANDLING AV HUSINREDNING
BE854908A (en) NEW ARYL TRIFLUOROETHYLAMINES, METHODS OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING
FI791424A7 (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, process for their preparation and pharmaceutical compositions containing them.
DK461579A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ARYLTRIFLUORETHANOL
IT8023103A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALCOHOL POISONING.
AR230924A1 (en) INSECTICIDE COMPOSITION OF FOSMET-DIFLUBENZURON
BE867040A (en) PHARMACEUTICAL COMPOSITION CONTAINING A NITRO-IMIDAZOLE
BE890011A (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING ALMITRIN
BE866422R (en) NEW CEPHALOSPORINS, THEIR PREPARATION AND COMPOSITIONS CONTAINING
PT68091A (en) PROCESS FOR THE PREPARATION OF A HERBICID COMPOSITION CONTAINING DIURETANE
IT7951182A0 (en) BN-183B ANTIBIOTIC, PROCEDURE FOR PRODUCING IT AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: FUJISAWA PHARMACEUTICAL CO. LTD

Effective date: 19991008